VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

SABCS 2020 | RxPONDER: sparing chemotherapy in node-positive early-stage breast cancer

Bora Lim, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses some key updates presented at this year’s virtual San Antonio Breast Cancer Symposium including the RxPONDER study which evaluated whether chemotherapy could be spared in women with node-positive early-stage breast cancer based on OncoType Dx ® score. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter